United States Pharmaceutical Contract Manufacturing and Contract Market Report & Forecast 2021-2027

Publisher Name :
Date: 23-Sep-2021
No. of pages: 113
Inquire Before Buying

United States Pharmaceutical Contract Manufacturing and Contract Market, By Type, 2016-2021, 2022-2027 ($ Millions)

United States Pharmaceutical Contract Manufacturing and Contract Market Segment Percentages, By Type, 2020 (%)

- Oral

- Injectable

- API

- Other

United States Pharmaceutical Contract Manufacturing and Contract Market, By Application, 2016-2021, 2022-2027 ($ Millions)

United States Pharmaceutical Contract Manufacturing and Contract Market Segment Percentages, By Application, 2020 (%)

- Small Medium Enterprise

- Large Enterprise

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Pharmaceutical Contract Manufacturing and Contract revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Pharmaceutical Contract Manufacturing and Contract revenues share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Catalent

- Thermo Fisher Scientific

- Lonza

- Boehringer Ingelheim

- Fareva

- Recipharm

- Aenova

- AbbVie

- Baxter

- Nipro Corp

- Sopharma

- Famar

- Vetter

- Shandong Xinhua

- Piramal

- Mylan

- Dr. Reddy's

- Zhejiang Hisun

- Zhejiang Huahai

- Jubilant

United States Pharmaceutical Contract Manufacturing and Contract Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Pharmaceutical Contract Manufacturing and Contract Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Pharmaceutical Contract Manufacturing and Contract Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Pharmaceutical Contract Manufacturing and Contract Overall Market Size
2.1 United States Pharmaceutical Contract Manufacturing and Contract Market Size: 2021 VS 2027
2.2 United States Pharmaceutical Contract Manufacturing and Contract Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pharmaceutical Contract Manufacturing and Contract Players in United States Market
3.2 Top United States Pharmaceutical Contract Manufacturing and Contract Companies Ranked by Revenue
3.3 United States Pharmaceutical Contract Manufacturing and Contract Revenue by Companies
3.4 Top 3 and Top 5 Pharmaceutical Contract Manufacturing and Contract Companies in United States Market, by Revenue in 2020
3.5 Companies Pharmaceutical Contract Manufacturing and Contract Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmaceutical Contract Manufacturing and Contract Players in United States Market
3.6.1 List of Tier 1 Pharmaceutical Contract Manufacturing and Contract Companies in United States
3.6.2 List of Tier 2 and Tier 3 Pharmaceutical Contract Manufacturing and Contract Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Pharmaceutical Contract Manufacturing and Contract Market Size Markets, 2021 & 2027
4.1.2 Oral
4.1.3 Injectable
4.1.4 API
4.1.5 Other
4.2 By Type - United States Pharmaceutical Contract Manufacturing and Contract Revenue & Forecasts
4.2.1 By Type - United States Pharmaceutical Contract Manufacturing and Contract Revenue, 2016-2021
4.2.2 By Type - United States Pharmaceutical Contract Manufacturing and Contract Revenue, 2022-2027
4.2.3 By Type - United States Pharmaceutical Contract Manufacturing and Contract Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Pharmaceutical Contract Manufacturing and Contract Market Size, 2021 & 2027
5.1.2 Small Medium Enterprise
5.1.3 Large Enterprise
5.2 By Application - United States Pharmaceutical Contract Manufacturing and Contract Revenue & Forecasts
5.2.1 By Application - United States Pharmaceutical Contract Manufacturing and Contract Revenue, 2016-2021
5.2.2 By Application - United States Pharmaceutical Contract Manufacturing and Contract Revenue, 2022-2027
5.2.3 By Application - United States Pharmaceutical Contract Manufacturing and Contract Revenue Market Share, 2016-2027
6 Pharmaceutical Contract Manufacturing and Contract Companies Profiles
6.1 Catalent
6.1.1 Catalent Company Details
6.1.2 Catalent Business Overview
6.1.3 Catalent Pharmaceutical Contract Manufacturing and Contract Introduction
6.1.4 Catalent Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021)
6.1.5 Catalent Recent Developments
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Company Details
6.2.2 Thermo Fisher Scientific Business Overview
6.2.3 Thermo Fisher Scientific Pharmaceutical Contract Manufacturing and Contract Introduction
6.2.4 Thermo Fisher Scientific Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021)
6.2.5 Thermo Fisher Scientific Recent Developments
6.3 Lonza
6.3.1 Lonza Company Details
6.3.2 Lonza Business Overview
6.3.3 Lonza Pharmaceutical Contract Manufacturing and Contract Introduction
6.3.4 Lonza Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021)
6.3.5 Lonza Recent Developments
6.4 Boehringer Ingelheim
6.4.1 Boehringer Ingelheim Company Details
6.4.2 Boehringer Ingelheim Business Overview
6.4.3 Boehringer Ingelheim Pharmaceutical Contract Manufacturing and Contract Introduction
6.4.4 Boehringer Ingelheim Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021)
6.4.5 Boehringer Ingelheim Recent Developments
6.5 Fareva
6.5.1 Fareva Company Details
6.5.2 Fareva Business Overview
6.5.3 Fareva Pharmaceutical Contract Manufacturing and Contract Introduction
6.5.4 Fareva Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021)
6.5.5 Fareva Recent Developments
6.6 Recipharm
6.6.1 Recipharm Company Details
6.6.2 Recipharm Business Overview
6.6.3 Recipharm Pharmaceutical Contract Manufacturing and Contract Introduction
6.6.4 Recipharm Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021)
6.6.5 Recipharm Recent Developments
6.7 Aenova
6.7.1 Aenova Company Details
6.7.2 Aenova Business Overview
6.7.3 Aenova Pharmaceutical Contract Manufacturing and Contract Introduction
6.7.4 Aenova Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021)
6.7.5 Aenova Recent Developments
6.8 AbbVie
6.8.1 AbbVie Company Details
6.8.2 AbbVie Business Overview
6.8.3 AbbVie Pharmaceutical Contract Manufacturing and Contract Introduction
6.8.4 AbbVie Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021)
6.8.5 AbbVie Recent Developments
6.9 Baxter
6.9.1 Baxter Company Details
6.9.2 Baxter Business Overview
6.9.3 Baxter Pharmaceutical Contract Manufacturing and Contract Introduction
6.9.4 Baxter Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021)
6.9.5 Baxter Recent Developments
6.10 Nipro Corp
6.10.1 Nipro Corp Company Details
6.10.2 Nipro Corp Business Overview
6.10.3 Nipro Corp Pharmaceutical Contract Manufacturing and Contract Introduction
6.10.4 Nipro Corp Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021)
6.10.5 Nipro Corp Recent Developments
6.11 Sopharma
6.11.1 Sopharma Company Details
6.11.2 Sopharma Business Overview
6.11.3 Sopharma Pharmaceutical Contract Manufacturing and Contract Introduction
6.11.4 Sopharma Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021)
6.11.5 Sopharma Recent Developments
6.12 Famar
6.12.1 Famar Company Details
6.12.2 Famar Business Overview
6.12.3 Famar Pharmaceutical Contract Manufacturing and Contract Introduction
6.12.4 Famar Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021)
6.12.5 Famar Recent Developments
6.13 Vetter
6.13.1 Vetter Company Details
6.13.2 Vetter Business Overview
6.13.3 Vetter Pharmaceutical Contract Manufacturing and Contract Introduction
6.13.4 Vetter Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021)
6.13.5 Vetter Recent Developments
6.14 Shandong Xinhua
6.14.1 Shandong Xinhua Company Details
6.14.2 Shandong Xinhua Business Overview
6.14.3 Shandong Xinhua Pharmaceutical Contract Manufacturing and Contract Introduction
6.14.4 Shandong Xinhua Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021)
6.14.5 Shandong Xinhua Recent Developments
6.15 Piramal
6.15.1 Piramal Company Details
6.15.2 Piramal Business Overview
6.15.3 Piramal Pharmaceutical Contract Manufacturing and Contract Introduction
6.15.4 Piramal Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021)
6.15.5 Piramal Recent Developments
6.16 Mylan
6.16.1 Mylan Company Details
6.16.2 Mylan Business Overview
6.16.3 Mylan Pharmaceutical Contract Manufacturing and Contract Introduction
6.16.4 Mylan Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021)
6.16.5 Mylan Recent Developments
6.17 Dr. Reddy's
6.17.1 Dr. Reddy's Company Details
6.17.2 Dr. Reddy's Business Overview
6.17.3 Dr. Reddy's Pharmaceutical Contract Manufacturing and Contract Introduction
6.17.4 Dr. Reddy's Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021)
6.17.5 Dr. Reddy's Recent Developments
6.18 Zhejiang Hisun
6.18.1 Zhejiang Hisun Company Details
6.18.2 Zhejiang Hisun Business Overview
6.18.3 Zhejiang Hisun Pharmaceutical Contract Manufacturing and Contract Introduction
6.18.4 Zhejiang Hisun Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021)
6.18.5 Zhejiang Hisun Recent Developments
6.19 Zhejiang Huahai
6.19.1 Zhejiang Huahai Company Details
6.19.2 Zhejiang Huahai Business Overview
6.19.3 Zhejiang Huahai Pharmaceutical Contract Manufacturing and Contract Introduction
6.19.4 Zhejiang Huahai Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021)
6.19.5 Zhejiang Huahai Recent Developments
6.20 Jubilant
6.20.1 Jubilant Company Details
6.20.2 Jubilant Business Overview
6.20.3 Jubilant Pharmaceutical Contract Manufacturing and Contract Introduction
6.20.4 Jubilant Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021)
6.20.5 Jubilant Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Pharmaceutical Contract Manufacturing and Contract Market Opportunities & Trends in United States Market
Table 2. Pharmaceutical Contract Manufacturing and Contract Market Drivers in United States Market
Table 3. Pharmaceutical Contract Manufacturing and Contract Market Restraints in United States Market
Table 4. Key Players of Pharmaceutical Contract Manufacturing and Contract in United States Market
Table 5. Top Pharmaceutical Contract Manufacturing and Contract Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Pharmaceutical Contract Manufacturing and Contract Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Pharmaceutical Contract Manufacturing and Contract Revenue Share by Companies, 2016-2021
Table 8. Companies Pharmaceutical Contract Manufacturing and Contract Product Type
Table 9. List of Tier 1 Pharmaceutical Contract Manufacturing and Contract Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Pharmaceutical Contract Manufacturing and Contract Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Pharmaceutical Contract Manufacturing and Contract Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Pharmaceutical Contract Manufacturing and Contract Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Pharmaceutical Contract Manufacturing and Contract Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Pharmaceutical Contract Manufacturing and Contract Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Pharmaceutical Contract Manufacturing and Contract Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Pharmaceutical Contract Manufacturing and Contract Revenue (US$, Mn), 2022-2027
Table 17. Catalent Company Details
Table 18. Catalent Business Overview
Table 19. Catalent Pharmaceutical Contract Manufacturing and Contract Product
Table 20. Catalent Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Catalent Recent Developments
Table 22. Thermo Fisher Scientific Company Details
Table 23. Thermo Fisher Scientific Business Overview
Table 24. Thermo Fisher Scientific Pharmaceutical Contract Manufacturing and Contract Product
Table 25. Thermo Fisher Scientific Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Thermo Fisher Scientific Recent Developments
Table 27. Lonza Company Details
Table 28. Lonza Business Overview
Table 29. Lonza Pharmaceutical Contract Manufacturing and Contract Product
Table 30. Lonza Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Lonza Recent Developments
Table 32. Boehringer Ingelheim Company Details
Table 33. Boehringer Ingelheim Business Overview
Table 34. Boehringer Ingelheim Pharmaceutical Contract Manufacturing and Contract Product
Table 35. Boehringer Ingelheim Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Boehringer Ingelheim Recent Developments
Table 37. Fareva Company Details
Table 38. Fareva Business Overview
Table 39. Fareva Pharmaceutical Contract Manufacturing and Contract Product
Table 40. Fareva Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Fareva Recent Developments
Table 42. Recipharm Company Details
Table 43. Recipharm Business Overview
Table 44. Recipharm Pharmaceutical Contract Manufacturing and Contract Product
Table 45. Recipharm Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Recipharm Recent Developments
Table 47. Aenova Company Details
Table 48. Aenova Business Overview
Table 49. Aenova Pharmaceutical Contract Manufacturing and Contract Product
Table 50. Aenova Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Aenova Recent Developments
Table 52. AbbVie Company Details
Table 53. AbbVie Business Overview
Table 54. AbbVie Pharmaceutical Contract Manufacturing and Contract Product
Table 55. AbbVie Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. AbbVie Recent Developments
Table 57. Baxter Company Details
Table 58. Baxter Business Overview
Table 59. Baxter Pharmaceutical Contract Manufacturing and Contract Product
Table 60. Baxter Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. Baxter Recent Developments
Table 62. Nipro Corp Company Details
Table 63. Nipro Corp Business Overview
Table 64. Nipro Corp Pharmaceutical Contract Manufacturing and Contract Product
Table 65. Nipro Corp Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. Nipro Corp Recent Developments
Table 67. Sopharma Company Details
Table 68. Sopharma Business Overview
Table 69. Sopharma Pharmaceutical Contract Manufacturing and Contract Product
Table 70. Sopharma Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021) & (US$ Million)
Table 71. Sopharma Recent Developments
Table 72. Famar Company Details
Table 73. Famar Business Overview
Table 74. Famar Pharmaceutical Contract Manufacturing and Contract Product
Table 75. Famar Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021) & (US$ Million)
Table 76. Famar Recent Developments
Table 77. Vetter Company Details
Table 78. Vetter Business Overview
Table 79. Vetter Pharmaceutical Contract Manufacturing and Contract Product
Table 80. Vetter Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021) & (US$ Million)
Table 81. Vetter Recent Developments
Table 82. Shandong Xinhua Company Details
Table 83. Shandong Xinhua Business Overview
Table 84. Shandong Xinhua Pharmaceutical Contract Manufacturing and Contract Product
Table 85. Shandong Xinhua Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021) & (US$ Million)
Table 86. Shandong Xinhua Recent Developments
Table 87. Piramal Business Overview
Table 88. Piramal Company Details
Table 89. Piramal Pharmaceutical Contract Manufacturing and Contract Product
Table 90. Piramal Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021) & (US$ Million)
Table 91. Piramal Recent Developments
Table 92. Mylan Company Details
Table 93. Mylan Business Overview
Table 94. Mylan Pharmaceutical Contract Manufacturing and Contract Product
Table 95. Mylan Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021) & (US$ Million)
Table 96. Mylan Recent Developments
Table 97. Dr. Reddy's Company Details
Table 98. Dr. Reddy's Business Overview
Table 99. Dr. Reddy's Pharmaceutical Contract Manufacturing and Contract Product
Table 100. Dr. Reddy's Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021) & (US$ Million)
Table 101. Dr. Reddy's Recent Developments
Table 102. Zhejiang Hisun Company Details
Table 103. Zhejiang Hisun Business Overview
Table 104. Zhejiang Hisun Pharmaceutical Contract Manufacturing and Contract Product
Table 105. Zhejiang Hisun Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021) & (US$ Million)
Table 106. Zhejiang Hisun Recent Developments
Table 107. Zhejiang Huahai Company Details
Table 108. Zhejiang Huahai Business Overview
Table 109. Zhejiang Huahai Pharmaceutical Contract Manufacturing and Contract Product
Table 110. Zhejiang Huahai Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021) & (US$ Million)
Table 111. Zhejiang Huahai Recent Developments
Table 112. Jubilant Company Details
Table 113. Jubilant Business Overview
Table 114. Jubilant Pharmaceutical Contract Manufacturing and Contract Product
Table 115. Jubilant Pharmaceutical Contract Manufacturing and Contract Revenue in United States Market (2016-2021) & (US$ Million)
Table 116. Jubilant Recent Developments
List of Figures
Figure 1. Pharmaceutical Contract Manufacturing and Contract Segment by Type
Figure 2. Pharmaceutical Contract Manufacturing and Contract Segment by Application
Figure 3. United States Pharmaceutical Contract Manufacturing and Contract Market Overview: 2020
Figure 4. United States Pharmaceutical Contract Manufacturing and Contract Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Pharmaceutical Contract Manufacturing and Contract Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Pharmaceutical Contract Manufacturing and Contract Revenue in 2020
Figure 7. By Type - United States Pharmaceutical Contract Manufacturing and Contract Revenue Market Share, 2016-2027
Figure 8. By Application - United States Pharmaceutical Contract Manufacturing and Contract Revenue Market Share, 2016-2027
Figure 9. Catalent Pharmaceutical Contract Manufacturing and Contract Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Thermo Fisher Scientific Pharmaceutical Contract Manufacturing and Contract Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Lonza Pharmaceutical Contract Manufacturing and Contract Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Boehringer Ingelheim Pharmaceutical Contract Manufacturing and Contract Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Fareva Pharmaceutical Contract Manufacturing and Contract Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Recipharm Pharmaceutical Contract Manufacturing and Contract Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Aenova Pharmaceutical Contract Manufacturing and Contract Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. AbbVie Pharmaceutical Contract Manufacturing and Contract Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Baxter Pharmaceutical Contract Manufacturing and Contract Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Nipro Corp Pharmaceutical Contract Manufacturing and Contract Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Sopharma Pharmaceutical Contract Manufacturing and Contract Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. Famar Pharmaceutical Contract Manufacturing and Contract Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Vetter Pharmaceutical Contract Manufacturing and Contract Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Shandong Xinhua Pharmaceutical Contract Manufacturing and Contract Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Piramal Pharmaceutical Contract Manufacturing and Contract Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Mylan Pharmaceutical Contract Manufacturing and Contract Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Dr. Reddy's Pharmaceutical Contract Manufacturing and Contract Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Zhejiang Hisun Pharmaceutical Contract Manufacturing and Contract Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Zhejiang Huahai Pharmaceutical Contract Manufacturing and Contract Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Jubilant Pharmaceutical Contract Manufacturing and Contract Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs